Found: 19
Select item for more details and to access through your institution.
Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28524-0
- By:
- Publication type:
- Article
Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer.
- Published in:
- Current Oncology, 2021, v. 28, n. 2, p. 1472, doi. 10.3390/curroncol28020139
- By:
- Publication type:
- Article
Patient selection for a developmental therapeutics program using whole genome and Transcriptome analysis.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1601, doi. 10.1007/s10637-020-00892-8
- By:
- Publication type:
- Article
Basal Breast Cancer Molecular Subtype Predicts for Lower Incidence of Axillary Lymph Node Metastases in Primary Breast Cancer.
- Published in:
- Clinical Cancer Update, 2008, v. 2, n. 1, p. 28, doi. 10.3816/CCU.2008.n.005
- By:
- Publication type:
- Article
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 4, p. 311, doi. 10.1007/s10637-005-1439-x
- By:
- Publication type:
- Article
Risk of Early Recurrence Among Postmenopausal Women With Estrogen Receptor-positive Early Breast Cancer Treated With Adjuvant Tamoxifen.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 7, p. 1437, doi. 10.1002/cncr.23320
- By:
- Publication type:
- Article
The Impact of New Chemotherapeutic and Hormone Agents on Survival in a Population-based Cohort of Women with Metastatic Breast Cancer.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 5, p. 973, doi. 10.1002/cncr.22867
- By:
- Publication type:
- Article
Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.
- Published in:
- Histopathology, 2017, v. 70, n. 2, p. 185, doi. 10.1111/his.13038
- By:
- Publication type:
- Article
Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 1, p. 12, doi. 10.1634/theoncologist.2016-0185
- By:
- Publication type:
- Article
Molecular Alterations Between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor.
- Published in:
- Oncologist, 2012, v. 17, n. 2, p. 172, doi. 10.1634/theoncologist.2011-0127
- By:
- Publication type:
- Article
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1302, doi. 10.1093/jnci/djad078
- By:
- Publication type:
- Article
Response: Re: Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 10, p. 736, doi. 10.1093/jnci/djp082
- By:
- Publication type:
- Article
Current Challenges and Disparities in the Delivery of Equitable Breast Cancer Care in Canada.
- Published in:
- Current Oncology, 2023, v. 30, n. 8, p. 7263, doi. 10.3390/curroncol30080527
- By:
- Publication type:
- Article